吉西他滨联合顺铂治疗晚期非小细胞肺癌28例临床观察
摘要
目的观察吉西他滨联合顺铂治疗晚期非小细胞肺癌临床疗效及不良反应。方法28例患者采用吉西他滨1g/m2第1、8、15天给药,顺铂90mg/m2分两天第2、3天化疗。28天为1周期,3周期评价疗效。结果28例可评价疗效和不良反应。初治病例RR为56.3%;复治病例RR为25%。主要不良反应为骨髓抑制。结论吉西他滨联合顺铂治疗晚期非小细胞肺癌有效率较高,不良反应可以耐受。
出处
《四川肿瘤防治》
2005年第2期93-94,共2页
Sichuan Journal of Cancer Control
参考文献4
-
1胡毅,冯奉仪.晚期非小细胞肺癌化疗研究现状及展望[J].国外医学(肿瘤学分册),2002,29(3):197-201. 被引量:45
-
2Moorsel CJAV, Veeman AM, Mosselman S, et al. Combination chemotherapy studies with gemcitabine[ J]. Semin Oncol, 1997,24(2suppl 17): 17.
-
3Sandler A,Nemunaitis J,denham C,et al. Phase Ⅲ trial of gemcitabine plus cisplatin versus cispatin alone in patients with locally advance or metastatic non-small cell lung cancer[J]. J Clin Oncol,2000,18( 1):122.
-
4Crino L, Scagliotti G, Marangolo M, et al. Cisplatin-gemcitabine combination in advance non-small cell lung cancer:A phase Ⅱ study [J]Clin Oncol, 1997,15 ( 1 ): 297.
二级参考文献20
-
1Greenlee RT, Murray T, Bolden S, et al. Cancer Statistics [J]. CA Cancer J Clin, 2000,50 (1):7-33.
-
2Feld R, Abratt R, Graziano S, et al. Pretreatment minimal staging and prognostic factors for non small cell hung cancer [J]. Lung Cancer,1997,17(Suppl 1 ):S3-10.
-
3Graziano SL, Kern JA, Herndon JE, et al . Analysis of neuroendcrine markersHER2 and CEA before and after chemotherapy in patients with stage Ⅲ A non small cell lung cancer: a Cancer and Leukemia Group B study[J]. Lung Cancer, 1997,21 (3) : 203-211.
-
4Rafael R , Mark G, Paul G. Adervances in the treatment of non-small cell lung cancer: molecular markers take the stage [J]. Sem Oncol, 2001,1 (28)28-34.
-
5Cullen MH, Billingham, LJ, Woodroffe CM, et al. Mitomycin, ifosfarnide, and cisplatin in unresectable non-small cell lung cancer:effects on survival and quality of life[J]. J Clin Oncol, 1999,17(10):3188-3194.
-
6Anderson H, Hopwood P, Stephens RJ, et al. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer-a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group [J]. Anticancer Res, 2000, 20 (3B):2229-2233.
-
7Wozniak A J, Crowley JJ, Ba Lcerzak SP, et al. Randomized trial comparing cixplatin with a splatin plus vinorelbine in the tzeatment of advanced non-small-cell lung cancer:a Southwest Oncology Group Study [J]. J Clin Oncol, 1998,16(7):2459-2465.
-
8Sandier A,Nemunaitis J,Denham C, et al. Phase Ⅲ trial of gemcitabine plus cisplatin vesus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer [J]. J Clin Oncol,2000, 18(1) : 122-130.
-
9von Pawel J, von Roemeling R, Gatzemeier U, et al. Tirapazarmine plus cisplatin versus cisplatin in advanced non small cell lung cancer:A report of the international CATAPULT study group . Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors[J]. J Ctin Oncol, 2000, 18(6):1351-1359.
-
10Gatzemeier U, von Pawel J,Gottfried M, et al. Phase Ⅲ comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small cell lung cancer [J]. J Clin Oncol, 2000,18(19):3390-3399.
共引文献44
-
1黄韵坚,黄诚,庄武,许凌,林金兰.吉西他滨联合奥沙利铂或顺铂治疗晚期非小细胞肺癌的随机对照研究[J].中华肿瘤防治杂志,2008,15(12):924-926. 被引量:8
-
2胡毅,高燕宁,冯奉仪,林冬梅,焦顺昌.比较基因组杂交技术分析晚期非小细胞肺癌一线化疗耐药及疗效[J].中国医学科学院学报,2010,32(4):389-393.
-
3孙祥,姚荣杰,李成发.非小细胞肺癌50例化疗临床观察[J].中国临床保健杂志,2004,7(3):208-208.
-
4汪济东,姜庆玲,汪雪原,张扬.NP方案化学治疗为主的综合治疗晚期非小细胞肺癌[J].临床肿瘤学杂志,2004,9(4):411-412. 被引量:5
-
5张继宝,刘桂英,蒋雪超,吴建亮.化放疗序贯治疗局部晚期非小细胞肺癌疗效观察[J].中国肿瘤临床与康复,2004,11(5):461-463. 被引量:2
-
6孙清,华军,常树建,毛永杰.长春瑞滨和顺铂联合同步放疗治疗局部晚期非小细胞肺癌临床研究[J].中国肿瘤临床与康复,2005,12(3):239-241. 被引量:5
-
7赵新,蔡晓虹,蒲小燕,赵军,王理扬.长春瑞滨联合顺铂治疗晚期非小细胞肺癌96例临床分析[J].中国肺癌杂志,2005,8(4):303-303.
-
8周欣,王晓文.长春瑞滨加顺铂治疗晚期非小细胞肺癌的临床观察[J].新疆医学,2005,35(4):1-2.
-
9孙清,华军,杭晓声,毛永杰,王琦.吉西他滨联合奥沙利铂或顺铂治疗老年人晚期非小细胞肺癌的随机对照临床研究[J].中国肺癌杂志,2005,8(5):451-453. 被引量:12
-
10孙清,毛永杰,华军,孙银萍.吉西他滨联合奥沙利铂治疗晚期非小细胞肺癌[J].临床肿瘤学杂志,2005,10(2):154-156. 被引量:8
-
1陈雅敏,刘基巍,赵翌.吉西他滨联合顺铂治疗晚期非小细胞肺癌46例报道[J].癌症进展,2004,2(4):285-287. 被引量:6
-
2侯梅,李慧,邱萌,李潞,鄢希.吉西他滨联合顺铂治疗晚期非小细胞肺癌临床研究[J].中国肺癌杂志,2001,4(3):191-193. 被引量:15
-
3潘荣强,李光明,文世民,任大成,别俊.周剂量紫杉醇联合顺铂治疗晚期乳腺癌的临床观察[J].西部医学,2009,21(6):914-915.
-
4姜西玲,赵新汉.奥沙利铂联合5-FU和吡柔比星治疗晚期胃癌临床疗效分析[J].现代肿瘤医学,2010,18(1):117-118. 被引量:7
-
5梁进,赵金奇,何文杰.周剂量紫杉醇治疗晚期高龄非小细胞肺癌的临床研究[J].现代肿瘤医学,2007,15(4):533-534.
-
6林懿,林英城,林文照,王鸿彪,曾德,林穗玲,霍霞.NVB加DDP联合化疗治疗48例晚期非小细胞肺癌疗效观察[J].中国肺癌杂志,2005,8(1):51-53. 被引量:3
-
7郑国文.盖诺联合CBP、CTX治疗NSCLC临床分析[J].黑龙江医药科学,2008,31(5):93-93.
-
8周长芳,彭猛青,陆锡燕,刘金平.奥沙利铂联合氟尿嘧啶及呲喃阿霉素治疗晚期胃癌36例临床观察[J].基层医学论坛,2004,8(11):977-978. 被引量:1
-
9黄慧强,管忠震,何友兼.米托蒽醌单药治疗鼻咽癌的Ⅱ期临床报告[J].癌症,1996,15(6):443-445. 被引量:4
-
10陈绍水,宁方玲,郭毅,吕俊华.NP和CAF方案治疗晚期乳腺癌疗效及副反应分析[J].滨州医学院学报,2005,28(3):165-166. 被引量:2